My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia.

    Al-Shaer MH, Choueiri NE, Suleiman ES.

    Lipids Health Dis. 2004 Oct 7;3:22.PMID: 15471540 [PubMed]Related articlesFree article

    2.

    Ezetimibe: a selective cholesterol absorption inhibitor.

    Nutescu EA, Shapiro NL.

    Pharmacotherapy. 2003 Nov;23(11):1463-74. Review.PMID: 14620392 [PubMed - indexed for MEDLINE]Related articles

    3.

    Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

    J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.PMID: 15650343 [PubMed - indexed for MEDLINE]Related articles

    4.

    Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

    Tenenbaum A, Fisman EZ, Motro M, Adler Y.

    Adv Cardiol. 2008;45:127-53. Review.PMID: 18230960 [PubMed - indexed for MEDLINE]Related articles

    5.

    Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage.

    [No authors listed]

    Prescrire Int. 2004 Oct;13(73):176-9.PMID: 15499698 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation.

    Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, Paisley S, Chilcott J.

    Health Technol Assess. 2008 May;12(21):iii, xi-xiii, 1-212. Review.PMID: 18485273 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

    Daskalopoulou SS, Mikhailidis DP.

    Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.PMID: 16574035 [PubMed - indexed for MEDLINE]Related articles

    8.

    Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

    Mikhailidis DP, Sibbring GC, Ballantyne CM, Davies GM, Catapano AL.

    Curr Med Res Opin. 2007 Aug;23(8):2009-26.PMID: 17659159 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cholesterol absorption inhibitors: defining new options in lipid management.

    Brown WV.

    Clin Cardiol. 2003 Jun;26(6):259-64. Review.PMID: 12839042 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia.

    Yamaoka-Tojo M, Tojo T, Kosugi R, Hatakeyama Y, Yoshida Y, Machida Y, Aoyama N, Masuda T, Izumi T.

    Lipids Health Dis. 2009 Oct 12;8:41.PMID: 19821987 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia.

    Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M, Uemura A, Yoshida S, Matsubara Y, Kani A, Hasegawa K, Hishida H, Ozaki Y.

    J Atheroscler Thromb. 2010 Feb;17(1):106-14. Epub 2010 Jan 14.PMID: 20075600 [PubMed - in process]Related articlesFree article

    12.

    Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.

    Sharma M, Ansari MT, Abou-Setta AM, Soares-Weiser K, Ooi TC, Sears M, Yazdi F, Tsertsvadze A, Moher D.

    Ann Intern Med. 2009 Nov 3;151(9):622-30. Review.PMID: 19884623 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.

    Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.

    Am J Cardiol. 2009 Feb 1;103(3):369-74. Epub 2008 Oct 30.PMID: 19166691 [PubMed - indexed for MEDLINE]Related articles

    14.

    Perspectives on low-density lipoprotein cholesterol goal achievement.

    Catapano AL.

    Curr Med Res Opin. 2009 Feb;25(2):431-47. Review.PMID: 19192988 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cholesterol absorption blockade with ezetimibe.

    Toth PP, Davidson MH.

    Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):455-62. Review.PMID: 16503865 [PubMed - indexed for MEDLINE]Related articles

    16.

    Ezetimibe for management of hypercholesterolemia.

    Mauro VF, Tuckerman CE.

    Ann Pharmacother. 2003 Jun;37(6):839-48. Review.PMID: 12773075 [PubMed - indexed for MEDLINE]Related articles

    17.

    Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.

    Chow D, Chen H, Glesby MJ, Busti A, Souza S, Andersen J, Kohrs S, Wu J, Koletar SL.

    AIDS. 2009 Oct 23;23(16):2133-41.PMID: 19770624 [PubMed - in process]Related articlesFree article

    18.

    Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On Study.

    Bissonnette S, Habib R, Sampalis F, Boukas S, Sampalis JS; Ezetrol Add-On Investigators.

    Can J Cardiol. 2006 Oct;22(12):1035-44. Erratum in: Can J Cardiol. 2007 Feb;23(2):159. PMID: 17036098 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.

    Assmann G, Kannenberg F, Ramey DR, Musliner TA, Gutkin SW, Veltri EP.

    Curr Med Res Opin. 2008 Jan;24(1):249-59.PMID: 18053317 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

    Clin Ther. 2008 Jan;30(1):84-97.PMID: 18343245 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk